[{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203 221 7381", "fax": "203 557 3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 65, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 597007, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 416930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 64, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 260898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 60, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4853, "open": 0.49, "dayLow": 0.4301, "dayHigh": 0.5027, "regularMarketPreviousClose": 0.4853, "regularMarketOpen": 0.49, "regularMarketDayLow": 0.4301, "regularMarketDayHigh": 0.5027, "payoutRatio": 0.0, "beta": 4.058, "forwardPE": -0.385678, "volume": 5560724, "regularMarketVolume": 5560724, "averageVolume": 30759311, "averageVolume10days": 170156890, "averageDailyVolume10Day": 170156890, "bid": 0.46, "ask": 0.5075, "bidSize": 1, "askSize": 7, "marketCap": 27305530, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 3.399, "allTimeHigh": 11.44, "allTimeLow": 0.185, "fiftyDayAverage": 0.31692, "twoHundredDayAverage": 0.914105, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20746114, "profitMargins": 0.0, "floatShares": 41076219, "sharesOutstanding": 59998965, "sharesShort": 2253998, "sharesShortPriorMonth": 254272, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.045900002, "heldPercentInsiders": 0.10381, "heldPercentInstitutions": 0.054369997, "shortRatio": 0.44, "shortPercentOfFloat": 0.048, "impliedSharesOutstanding": 59998966, "bookValue": 0.193, "priceToBook": 2.358031, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12578000, "trailingEps": -0.82, "forwardEps": -1.18, "52WeekChange": -0.8484375, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 0.4551, "targetHighPrice": 5.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.91667, "targetMedianPrice": 3.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 2216000, "totalCashPerShare": 0.047, "totalDebt": 125000, "quickRatio": 1.024, "currentRatio": 1.404, "debtToEquity": 5.723, "returnOnAssets": -1.22675, "returnOnEquity": -3.3412101, "freeCashflow": -6337000, "operatingCashflow": -11085000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INTS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.22296, "regularMarketPrice": 0.4551, "messageBoardId": "finmb_225412349", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1762563103, "regularMarketTime": 1762549201, "exchange": "NCM", "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "epsTrailingTwelveMonths": -0.82, "epsForward": -1.18, "epsCurrentYear": -0.365, "priceEpsCurrentYear": -1.2468493, "fiftyDayAverageChange": 0.13817999, "fiftyDayAverageChangePercent": 0.43600902, "twoHundredDayAverageChange": -0.459005, "twoHundredDayAverageChangePercent": -0.502136, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-06-30", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1688131800000, "postMarketChangePercent": -0.8789295, "postMarketPrice": 0.4511, "postMarketChange": -0.004000008, "regularMarketChange": -0.0302, "regularMarketDayRange": "0.4301 - 0.5027", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 30759311, "fiftyTwoWeekLowChange": 0.2701, "fiftyTwoWeekLowChangePercent": 1.4599999, "fiftyTwoWeekRange": "0.185 - 3.399", "fiftyTwoWeekHighChange": -2.9438999, "fiftyTwoWeekHighChangePercent": -0.86610764, "fiftyTwoWeekChangePercent": -84.84375, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "displayName": "Intensity Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]